Insulin drug prices international vs US comparison 2018

Although there was variation in price between select insulin drugs, in all cases the U.S. price per dose was higher than the average of the 11 other countries in this analysis. This statistic shows the average U.S. and non-U.S. price per dose of select insulin drugs, based on 2018 data.

Price comparison U.S. vs. international per dose for select insulin drugs in 2018* (in U.S. dollars)

Characteristic	U.S. price	Average (excluding U.S.) price
Toujeo Solostar	82.74	16.37
NovoLOG Flexpen	37.26	7.26
NovoLOG	36.55	8.69
HumaLOG KwikPen U-100	35.36	7.75
HumaLOG Mix 75-25 KwikPen	35.36	6.75
Lantus	29.96	15
Lantus SoloStar	26.95	15.86

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

September 2019

More information

Region

Worldwide

Survey time period

2018

Supplementary notes

* Based on price data for 2018, collected from recognized price sources. Countries included in the analysis: United States, United Kingdom, Japan, Canada, Australia, Portugal, France, the Netherlands, Germany, Denmark, Sweden, and Switzerland. Comparison is with U.S. drug prices under Medicare Part D. Information on the types of insulin were retrieved from Cleveland Clinic “Injectable Insulin Medications” article.

Citation formats